Your browser doesn't support javascript.
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
Hansen, Cecilie Bo; Jarlhelt, Ida; Hasselbalch, Rasmus Bo; Hamm, Sebastian Rask; Fogh, Kamille; Pries-Heje, Mia Marie; Møller, Dina Leth; Heftdal, Line Dam; Pérez-Alós, Laura; Sørensen, Erik; Larsen, Margit Anita Hørup; Skjoedt, Mikkel-Ole; Ostrowski, Sisse Rye; Frikke-Schmidt, Ruth; Bayarri-Olmos, Rafael; Hilsted, Linda Maria; Bundgaard, Henning; Nielsen, Susanne Dam; Iversen, Kasper Karmark; Garred, Peter.
  • Hansen CB; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Jarlhelt I; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Hasselbalch RB; Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Hamm SR; Department of Emergency medicine, Herlev and Gentofte Hospital, University of Copenhagen, Denmark.
  • Fogh K; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pries-Heje MM; Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Møller DL; Department of Emergency medicine, Herlev and Gentofte Hospital, University of Copenhagen, Denmark.
  • Heftdal LD; Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Pérez-Alós L; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Sørensen E; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Larsen MAH; Department of Haematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Skjoedt MO; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Ostrowski SR; Department of Clinical Immunology, Section 2034, Blood Bank, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Frikke-Schmidt R; Department of Clinical Immunology, Section 2034, Blood Bank, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bayarri-Olmos R; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Hilsted LM; Department of Clinical Immunology, Section 2034, Blood Bank, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bundgaard H; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Nielsen SD; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Iversen KK; Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Garred P; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
J Intern Med ; 290(6): 1272-1274, 2021 12.
Article in English | MEDLINE | ID: covidwho-1301530
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Messenger / Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: J Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: Joim.13366

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Messenger / Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: J Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: Joim.13366